This is specific to retatrutide and not typically seen with cagrilintide
For psoriasis and tendonitis (as mentioned by ryochs in our Discord), this offers: KLOW typically contains: BPC-157 (tissue repair, anti-inflammatory) TB-500 (systemic healing, flexibility) GHK-Cu (skin repair, collagen) KPV (in some formulationsNF-B inhibition) Advantages for psoriasis: Multiple anti-inflammatory pathways addressed simultaneously Convenience of single injection Synergistic repair mechanisms Disadvantages: Less control over individual peptide doses May not be optimized for skin-specific conditions If using KLOW for psoriasis: Standard dosing per the blend instructions (typically daily, 5 days on/2 off) Expect 48 weeks for noticeable skin changes Track lesion size, redness, and scaling for objective assessment What to Realistically Expect Peptides for psoriasis are adjunctive support , not a cure
Then, 1000 mcg weekly for a month, and 1000 mcg monthly after that
GHK-Cu can soften the look of fine lines and improve firmness, but it does so gradually by supporting your own collagen rather than freezing muscles or filling skin
Researchers evaluating Dihexa should be aware of the following: Retracted foundational paper
miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway